Yamashita Kazuto, Muir William W, Tsubakishita Sae, Abrahamsen Eric, Lerch Phillip, Hubbell John A E, Bednarski Richard M, Skarda Roman T, Izumisawa Yasuharu, Kotani Tadao
Department of Veterinary Surgery 1, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido, Japan.
J Am Vet Med Assoc. 2002 Oct 15;221(8):1144-9. doi: 10.2460/javma.2002.221.1144.
To compare the analgesic and cardiopulmonary effects of medetomidine and xylazine when used for premedication of horses undergoing general anesthesia.
Randomized clinical trial.
40 horses.
Twenty horses were premedicated with medetomidine (10 microg/kg [4.5 microg/lb], i.m.) and the other 20 were premedicated with xylazine (2 mg/kg [0.9 mg/kg], i.m.). Horses were then anesthetized with a combination of guaifenesin and ketamine; anesthesia was maintained with halothane. Additional doses of medetomidine or xylazine were given if horses were not sufficiently sedated at the time of anesthetic induction. After induction of anesthesia, sodium pentothal was administered as necessary to prevent limb movements. Hypotension was treated with dobutamine; hypoventilation and hypoxemia were treated with intermittent positive-pressure ventilation. The quality of anesthetic induction, maintenance, and recovery and the quality of the transition to inhalation anesthesia were scored.
Scores for the quality of the transition to inhalation anesthesia were significantly higher for horses premedicated with medetomidine than for horses premedicated with xylazine. However, other scores, recovery times, and numbers of attempts needed to achieve sternal recumbency and to stand were not significantly different between groups.
Results suggest that medetomidine is suitable for premedication of horses undergoing general anesthesia. Analgesic and cardiopulmonary effects of medetomidine were similar to those of xylazine, except that the transition to inhalation anesthesia was smoother when horses were premedicated with medetomidine, rather than xylazine.
比较美托咪定和赛拉嗪用于接受全身麻醉马匹的术前用药时的镇痛及心肺效应。
随机临床试验。
40匹马。
20匹马用美托咪定(10微克/千克[4.5微克/磅],肌肉注射)进行术前用药,另外20匹马用赛拉嗪(2毫克/千克[0.9毫克/磅],肌肉注射)进行术前用药。然后用愈创甘油醚和氯胺酮联合对马匹进行麻醉;用氟烷维持麻醉。如果马匹在麻醉诱导时镇静不足,则给予额外剂量的美托咪定或赛拉嗪。麻醉诱导后,必要时给予硫喷妥钠以防止肢体运动。用多巴酚丁胺治疗低血压;用间歇正压通气治疗通气不足和低氧血症。对麻醉诱导、维持和恢复的质量以及向吸入麻醉过渡的质量进行评分。
用美托咪定进行术前用药的马匹向吸入麻醉过渡的质量评分显著高于用赛拉嗪进行术前用药的马匹。然而,其他评分、恢复时间以及达到胸卧姿势和站立所需的尝试次数在两组之间没有显著差异。
结果表明美托咪定适用于接受全身麻醉马匹的术前用药。美托咪定的镇痛及心肺效应与赛拉嗪相似,只是当用美托咪定而非赛拉嗪对马匹进行术前用药时,向吸入麻醉的过渡更平稳。